BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 21186264)

  • 1. A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophy.
    Hicks D; Sarkozy A; Muelas N; Köehler K; Huebner A; Hudson G; Chinnery PF; Barresi R; Eagle M; Polvikoski T; Bailey G; Miller J; Radunovic A; Hughes PJ; Roberts R; Krause S; Walter MC; Laval SH; Straub V; Lochmüller H; Bushby K
    Brain; 2011 Jan; 134(Pt 1):171-182. PubMed ID: 21186264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel ANO5 mutations causing hyper-CK-emia, limb girdle muscular weakness and Miyoshi type of muscular dystrophy.
    Schessl J; Kress W; Schoser B
    Muscle Nerve; 2012 May; 45(5):740-2. PubMed ID: 22499103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANO5 gene analysis in a large cohort of patients with anoctaminopathy: confirmation of male prevalence and high occurrence of the common exon 5 gene mutation.
    Sarkozy A; Hicks D; Hudson J; Laval SH; Barresi R; Hilton-Jones D; Deschauer M; Harris E; Rufibach L; Hwang E; Bashir R; Walter MC; Krause S; van den Bergh P; Illa I; Pénisson-Besnier I; De Waele L; Turnbull D; Guglieri M; Schrank B; Schoser B; Seeger J; Schreiber H; Gläser D; Eagle M; Bailey G; Walters R; Longman C; Norwood F; Winer J; Muntoni F; Hanna M; Roberts M; Bindoff LA; Brierley C; Cooper RG; Cottrell DA; Davies NP; Gibson A; Gorman GS; Hammans S; Jackson AP; Khan A; Lane R; McConville J; McEntagart M; Al-Memar A; Nixon J; Panicker J; Parton M; Petty R; Price CJ; Rakowicz W; Ray P; Schapira AH; Swingler R; Turner C; Wagner KR; Maddison P; Shaw PJ; Straub V; Bushby K; Lochmüller H
    Hum Mutat; 2013 Aug; 34(8):1111-8. PubMed ID: 23606453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eight new mutations and the expanding phenotype variability in muscular dystrophy caused by ANO5.
    Penttilä S; Palmio J; Suominen T; Raheem O; Evilä A; Muelas Gomez N; Tasca G; Waddell LB; Clarke NF; Barboi A; Hackman P; Udd B
    Neurology; 2012 Mar; 78(12):897-903. PubMed ID: 22402862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency and characterisation of anoctamin 5 mutations in a cohort of Italian limb-girdle muscular dystrophy patients.
    Magri F; Del Bo R; D'Angelo MG; Sciacco M; Gandossini S; Govoni A; Napoli L; Ciscato P; Fortunato F; Brighina E; Bonato S; Bordoni A; Lucchini V; Corti S; Moggio M; Bresolin N; Comi GP
    Neuromuscul Disord; 2012 Nov; 22(11):934-43. PubMed ID: 22742934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recessive mutations in the putative calcium-activated chloride channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies.
    Bolduc V; Marlow G; Boycott KM; Saleki K; Inoue H; Kroon J; Itakura M; Robitaille Y; Parent L; Baas F; Mizuta K; Kamata N; Richard I; Linssen WH; Mahjneh I; de Visser M; Bashir R; Brais B
    Am J Hum Genet; 2010 Feb; 86(2):213-21. PubMed ID: 20096397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANO5 mutations in the Dutch limb girdle muscular dystrophy population.
    van der Kooi AJ; Ten Dam L; Frankhuizen WS; Straathof CS; van Doorn PA; de Visser M; Ginjaar IB
    Neuromuscul Disord; 2013 Jun; 23(6):456-60. PubMed ID: 23607914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective membrane fusion and repair in Anoctamin5-deficient muscular dystrophy.
    Griffin DA; Johnson RW; Whitlock JM; Pozsgai ER; Heller KN; Grose WE; Arnold WD; Sahenk Z; Hartzell HC; Rodino-Klapac LR
    Hum Mol Genet; 2016 May; 25(10):1900-1911. PubMed ID: 26911675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early-onset limb-girdle muscular dystrophy-2L in a female athlete.
    Blackburn PR; Selcen D; Jackson JL; Guthrie KJ; Cousin MA; Boczek NJ; Clift KE; Klee EW; Dimberg EL; Atwal PS
    Muscle Nerve; 2017 May; 55(5):E19-E21. PubMed ID: 27862037
    [No Abstract]   [Full Text] [Related]  

  • 10. [Muscular dystrophy due to mutations in anoctamin 5: clinical and molecular genetic findings].
    Deschauer M; Joshi PR; Gläser D; Hanisch F; Stoltenburg G; Zierz S
    Nervenarzt; 2011 Dec; 82(12):1596-603. PubMed ID: 21739273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First familial limb-girdle muscular dystrophy 2L in China: Clinical, imaging, pathological, and genetic features.
    Hu B; Xiong L; Zhou Y; Lu X; Xiong Q; Liu Q; Qi X; Ding W
    Medicine (Baltimore); 2018 Sep; 97(38):e12506. PubMed ID: 30235762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic Spectrum of Myopathies with Recessive Anoctamin-5 Mutations.
    Vázquez J; Lefeuvre C; Escobar RE; Luna Angulo AB; Miranda Duarte A; Delia Hernandez A; Brisset M; Carlier RY; Leturcq F; Durand-Canard MC; Nicolas G; Laforet P; Malfatti E
    J Neuromuscul Dis; 2020; 7(4):443-451. PubMed ID: 32925086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anoctamin-5 Muscular Dystrophy: Report of Two Cases with Different Phenotypes and Genotypes from the Indian Subcontinent.
    Mahajan S; Dhall A; Jassal B; Saluja A; Faruq M; Suri V; Rajan R; Vishnu VY; Sharma MC
    Neurol India; 2022; 70(5):2169-2173. PubMed ID: 36352632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANO5 mutations in the Polish limb girdle muscular dystrophy patients: Effects on the protein structure.
    Jarmula A; Łusakowska A; Fichna JP; Topolewska M; Macias A; Johnson K; Töpf A; Straub V; Rosiak E; Szczepaniak K; Dunin-Horkawicz S; Maruszak A; Kaminska AM; Redowicz MJ
    Sci Rep; 2019 Aug; 9(1):11533. PubMed ID: 31395899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anoctamin 5 Knockout Mouse Model Recapitulates LGMD2L Muscle Pathology and Offers Insight Into in vivo Functional Deficits.
    Thiruvengadam G; Sreetama SC; Charton K; Hogarth M; Novak JS; Suel-Petat L; Chandra G; Allard B; Richard I; Jaiswal JK
    J Neuromuscul Dis; 2021; 8(s2):S243-S255. PubMed ID: 34633328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mutations in the Anoctamin 5 gene (ANO5) associated with limb-girdle muscular dystrophy 2L.
    Little AA; McKeever PE; Gruis KL
    Muscle Nerve; 2013 Feb; 47(2):287-91. PubMed ID: 23169617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing clinical data and muscle imaging of DYSF and ANO5 related muscular dystrophies.
    Ten Dam L; van der Kooi AJ; Rövekamp F; Linssen WH; de Visser M
    Neuromuscul Disord; 2014 Dec; 24(12):1097-102. PubMed ID: 25176504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Japanese male with a novel ANO5 mutation with minimal muscle weakness and muscle pain till his late fifties.
    Kadoya M; Ogata K; Suzuki M; Honma Y; Momma K; Yatabe K; Tamura T; Kaida K; Miyata N; Nishino I; Nonaka I; Kawai M
    Neuromuscul Disord; 2017 May; 27(5):477-480. PubMed ID: 28214267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anoctamin 5 (ANO5) Muscle Disorders: A Narrative Review.
    Soontrapa P; Liewluck T
    Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Mutation in Anoctamin 5 Gene Causing Limb-Girdle Muscular Dystrophy 2L.
    Peddareddygari LR; Oberoi K; Baisre-De Leon A; Grewal RP
    J Clin Neuromuscul Dis; 2018 Jun; 19(4):228-231. PubMed ID: 29794579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.